MBSAX Fees and Costs — Multisector Bond SMA Completion Portfolio

Data updated: 2026-07-29

The net expense ratio is 0.00% (0.54% before fee waivers). There are no sales loads or redemption fees. Portfolio turnover was 656%.

MBSAX Fees and Expenses

Annual operating expenses and sales charges of MBSAX. Prospectus, as of August 31, 2025.

Annual operating expenses
Management fee0.00%
12b-1 fee0.00%
Other expenses0.53%
Gross expense ratio0.54%
Fee waiver−0.54%
Net expense ratio0.00%
Sales charges
Max front load0.00%
Max deferred load0.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentNo

MBSAX Costs Over Time

On $10,000 invested in MBSAX, assuming 5% a year before costs, total costs come to $0 over 5 years, cutting the return by 0.00% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.00%)$0$0$0
Lost growth on money paid in costs$0$0$0
Total costs$0$0$0
Value after costs$10,500$11,576$12,763
Impact on return, per year0.00%0.00%0.00%

MBSAX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2024.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $48.6M
  • Portfolio turnover (prospectus): 656%
  • Securities lending: none during the year

MBSAX Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
Wells Fargo$39.4M81.06%
Morgan Stanley$8.5M17.51%
Barclays$413K0.85%
Citadel Securities LLC$147K0.30%
JPMorgan$132K0.27%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.